XML 50 R31.htm IDEA: XBRL DOCUMENT v3.19.3
Reinsurance (Tables)
9 Months Ended
Sep. 30, 2019
Insurance [Abstract]  
Effects of reinsurance on premiums and benefits The effects of reinsurance on premiums written and contract deposits; premiums and contract charges earned; and benefits, claims and settlement expenses were as follows:
($ in thousands)
 
Gross
Amount
 
Ceded to
Other
Companies (1)
 
Assumed
from Other
Companies
 
Net
Amount
Three months ended September 30, 2019
 
 

 
 

 
 

 
 

Premiums written and contract deposits (2)
 
$
374,598

 
$
5,968

 
$
2,586

 
$
371,216

Premiums and contract charges earned
 
245,200

 
8,181

 
2,662

 
239,681

Benefits, claims and settlement expenses
 
154,718

 
2,310

 
1,783

 
154,191

 
 
 
 
 
 
 
 
 
Three months ended September 30, 2018
 
 

 
 

 
 

 
 

Premiums written and contract deposits (2)
 
$
342,268

 
$
5,370

 
$
1,199

 
$
338,097

Premiums and contract charges earned
 
210,953

 
5,385

 
1,252

 
206,820

Benefits, claims and settlement expenses
 
163,912

 
3,207

 
1,141

 
161,846

 
 
 
 
 
 
 
 
 
Nine months ended September 30, 2019
 
 
 
 
 
 
 
 
Premiums written and contract deposits (2)
 
$
988,588

 
$
17,844

 
$
7,557

 
$
978,301

Premiums and contract charges earned
 
671,871

 
22,158

 
7,849

 
657,562

Benefits, claims and settlement expenses
 
450,206

 
9,399

 
5,460

 
446,267

 
 
 
 
 
 
 
 
 
Nine months ended September 30, 2018
 
 
 
 
 
 
 
 
Premiums written and contract deposits (2)
 
$
936,948

 
$
16,367

 
$
3,246

 
$
923,827

Premiums and contract charges earned
 
628,582

 
16,418

 
3,264

 
615,428

Benefits, claims and settlement expenses
 
486,339

 
15,551

 
2,898

 
473,686


_____________
(1) 
Excludes the annuity reinsurance agreement accounted for under the deposit method that is discussed in Note 6.
(2) 
This measure is not based on accounting principles generally accepted in the U.S. (non-GAAP). An explanation of this non-GAAP measure is contained in the Glossary of Selected Terms included as an exhibit in the Company's reports filed with the SEC.